Researchers are exploring tumor heterogeneity, including its development, mechanisms, and implications for therapy. Various preclinical models, such as tumoroids and patient-derived xenografts, are being developed and utilized to study cancer and discover new treatments. These models and emerging technologies may have future applications in cancer research, drug discovery, and precision medicine.